Use of virus as therapeutic agent, other than vaccine

Industry

CPC
C12N2710/24132

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2710/00dsDNA Viruses

Current Industry

C12N2710/24132Use of virus as therapeutic agent, other than vaccine

Industries

Patents Grantslast 30 patents

Information Patent Grant
Chimeric poxvirus compositions and uses thereof
- Patent number 12,084,687
- Issue date Sep 10, 2024
- City of Hope
- Yuman Fong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 12,036,279
- Issue date Jul 16, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for modulating inflammatory responses
- Patent number 11,993,632
- Issue date May 28, 2024
- Duke University
- Francis Chan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,986,503
- Issue date May 21, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified orthopoxvirus vectors
- Patent number 11,802,292
- Issue date Oct 31, 2023
- Ottawa Hospital Research Institute
- John C. Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oncolytic virus for expression of immune checkpoint modulators
- Patent number 11,779,619
- Issue date Oct 10, 2023
- Transgene S.A.
- Nathalie Silvestre
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Engineered vaccinia virus
- Patent number 11,739,302
- Issue date Aug 29, 2023
- Shenzhen Hua Yao Kang Ming Biopharmaceutical Co., Ltd.
- Ming Yuan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant vaccinia virus and methods of use thereof
- Patent number 11,685,904
- Issue date Jun 27, 2023
- Ignite Immunotherapy, Inc.
- David H. Kirn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy by combination use of oncolytic vaccinia virus and i...
- Patent number 11,638,730
- Issue date May 2, 2023
- Astellas Pharma Inc.
- Shinsuke Nakao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immuno-modulated replication-efficient vaccinia virus strain
- Patent number 11,633,441
- Issue date Apr 25, 2023
- Gerd Sutter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,541,087
- Issue date Jan 3, 2023
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell-based vehicles for potentiation of viral therapy
- Patent number 11,505,782
- Issue date Nov 22, 2022
- Calidi Biotherapeutics, Inc.
- Dobrin Draganov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immuno-oncolytic therapies
- Patent number 11,478,518
- Issue date Oct 25, 2022
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic agents and uses thereof for drugs for treatment of tumo...
- Patent number 11,446,345
- Issue date Sep 20, 2022
- HANGZHOU CONVERD CO., LTD.
- Fang Hu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer oncolytic virus combination therapies and elite respond...
- Patent number 11,433,108
- Issue date Sep 6, 2022
- SUZHOU PRAJNA BIOTECH CO., LTD.
- Minjie Hu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of inactivated nonreplicating modified vaccinia virus Ankara (M...
- Patent number 11,426,460
- Issue date Aug 30, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically engineered vaccinia viruses
- Patent number 11,344,589
- Issue date May 31, 2022
- National University Corporation Tottori University
- Takafumi Nakamura
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...
- Patent number 11,285,209
- Issue date Mar 29, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oncolytic viruses targeting STAT3
- Patent number 11,253,559
- Issue date Feb 22, 2022
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
- Patent number 11,253,560
- Issue date Feb 22, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Schwann cell differentiation promoting agent and a peripheral nerve...
- Patent number 11,207,354
- Issue date Dec 28, 2021
- Osaka University
- Hiroyuki Tanaka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Clonal strains of attenuated vaccinia viruses and methods of use th...
- Patent number 11,149,254
- Issue date Oct 19, 2021
- Genelux Corporation
- Aladar A. Szalay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Test method
- Patent number 11,129,976
- Issue date Sep 28, 2021
- Osaka University
- Hiroyuki Tanaka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High mobility group box I mutant
- Patent number 11,065,286
- Issue date Jul 20, 2021
- Stephen H. Thorne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-genetic modification of enveloped viruses
- Patent number 10,982,194
- Issue date Apr 20, 2021
- VALO THERAPEUTICS OY
- Vincenzo Cerullo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment using oncolytic viruses
- Patent number 10,967,015
- Issue date Apr 6, 2021
- New York University
- Ian J Mohr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically engineered vaccinia viruses
- Patent number 10,888,594
- Issue date Jan 12, 2021
- National University Corporation Tottori University
- Shinsuke Nakao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Genetically engineered vaccinia viruses
- Patent number 10,849,946
- Issue date Dec 1, 2020
- National University Corporation Tottori University
- Shinsuke Nakao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oncolytic vaccinia virus mutants and using same for cancer treatment
- Patent number 10,842,835
- Issue date Nov 24, 2020
- Arizona Board of Regents on behalf of Arizona State University
- Bertram Jacobs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for production of vaccina virus
- Patent number 10,767,166
- Issue date Sep 8, 2020
- Sillajen Biotherapeutics, Inc.
- David Kirn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
- Publication number 20250041368
- Publication date Feb 6, 2025
- KaliVir Immunotherapeutics, Inc.
- Stephen Howard THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
- Publication number 20250009824
- Publication date Jan 9, 2025
- KaliVir Immunotherapeutics, Inc.
- Stephen Howard THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTERLEUKIN 7 AND INTERLEUKIN 21 FUSION PROTEINS
- Publication number 20250002551
- Publication date Jan 2, 2025
- ALLEGHENY-SINGER RESEARCH INSTITUTE
- David L. Bartlett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Expression of Bacterial Dinucleotide Cyclases
- Publication number 20240245804
- Publication date Jul 25, 2024
- McMaster University
- Brian Lichty
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED ORTHOPOXVIRUS VECTORS
- Publication number 20240229069
- Publication date Jul 11, 2024
- OTTAWA HOSPITAL RESEARCH INSTITUTE
- John C. BELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED ORTHOPOXVIRUS VECTORS
- Publication number 20240132913
- Publication date Apr 25, 2024
- OTTAWA HOSPITAL RESEARCH INSTITUTE
- John C. BELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUSES TARGETING STAT3
- Publication number 20240016865
- Publication date Jan 18, 2024
- UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH STSTEM OF HIGHER EDUCATION
- Stephen Howard Thorne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL RECOMBINANT VACCINIA VIRUS AND USE THEREOF
- Publication number 20230355691
- Publication date Nov 9, 2023
- NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY
- Takafumi NAKAMURA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNO-MODULATED REPLICATION-EFFICIENT VACCINIA VIRUS STRAIN
- Publication number 20230346863
- Publication date Nov 2, 2023
- Gerd SUTTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oncolytic Vaccinia Virus
- Publication number 20230293608
- Publication date Sep 21, 2023
- QUEEN MARY UNIVERSITY OF LONDON
- Yaohe Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
- Publication number 20230256041
- Publication date Aug 17, 2023
- KaliVir Immunotherapeutics, Inc.
- Stephen Howard THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT VACCINIA VIRUS
- Publication number 20230201283
- Publication date Jun 29, 2023
- Pfizer Inc.
- Joseph John Binder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF MANUFACTURING ACTIVATED IMMUNE CELLS
- Publication number 20230086531
- Publication date Mar 23, 2023
- BIOECLIPSE THERAPEUTICS, INC.
- Pamela Reilly CONTAG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20230057304
- Publication date Feb 23, 2023
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELL-BASED VEHICLES FOR POTENTIATION OF VIRAL THERAPY
- Publication number 20230022205
- Publication date Jan 26, 2023
- CALIDI BIOTHERAPEUTICS, INC.
- Dobrin Draganov
- G01 - MEASURING TESTING
Information Patent Application
Immuno-Oncolytic Therapies
- Publication number 20230008089
- Publication date Jan 12, 2023
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLONAL STRAINS OF ATTENUATED VACCINIA VIRUSES AND METHODS OF USE TH...
- Publication number 20230008052
- Publication date Jan 12, 2023
- Genelux Corporation
- Aladar A. SZALAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR M...
- Publication number 20220370527
- Publication date Nov 24, 2022
- Ansun Biopharma, Inc.
- Nancy Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING ANTICANCE...
- Publication number 20220362316
- Publication date Nov 17, 2022
- Bionoxx Inc.
- Tae-Ho Hwang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IRF MODULATOR-EXPRESSING ONCOLYTIC VIRUSES FOR TREATING CANCER
- Publication number 20220362317
- Publication date Nov 17, 2022
- University of Pittsburgh of the Commonwealth System of Higher Education
- Saumendra N. SARKAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...
- Publication number 20220339220
- Publication date Oct 27, 2022
- Hangzhou Converd Co., Ltd.
- Fang HU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF US...
- Publication number 20220290179
- Publication date Sep 15, 2022
- Astellas Pharma Inc.
- Shinsuke Nakao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING VACCINIA...
- Publication number 20220288143
- Publication date Sep 15, 2022
- Bionoxx Inc.
- Tae-Ho Hwang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Striatin interacting protein inhibitor and use thereof in preparati...
- Publication number 20220275370
- Publication date Sep 1, 2022
- HANGZHOU GONGCHU BIOTECHNOLOGY CO., LTD.
- Gongchu LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VACCINIA VIRUS
- Publication number 20220275347
- Publication date Sep 1, 2022
- KM Biologics Co., Ltd.
- Toshio MURAKAMI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF POXVIRUS WITH AUTOLOGOUS INDUCED PLURIPOTENT STEM CELLS FOR...
- Publication number 20220228128
- Publication date Jul 21, 2022
- IMMUNOLUX INTERNATIONAL CORP.
- Aladar SZALAY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUSES TARGETING STAT3
- Publication number 20220133825
- Publication date May 5, 2022
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC VIRUSES TARGETING STAT3
- Publication number 20220133824
- Publication date May 5, 2022
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED ONCOLYTIC VIRUSES EXPRESSING PD-L1 INHIBITORS AND USES T...
- Publication number 20220064672
- Publication date Mar 3, 2022
- University of Southern California
- Siyi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
M2-DEFECTIVE POXVIRUS
- Publication number 20220056481
- Publication date Feb 24, 2022
- TRANSGENE
- Patricia KLEINPETER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Use of virus as therapeutic agent, other than vaccine

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Chimeric poxvirus compositions and uses thereof

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Compositions and methods for modulating inflammatory responses

Replication competent attenuated vaccinia viruses with deletion of...

Modified orthopoxvirus vectors

Oncolytic virus for expression of immune checkpoint modulators

Engineered vaccinia virus

Recombinant vaccinia virus and methods of use thereof

Cancer therapy by combination use of oncolytic vaccinia virus and i...

Immuno-modulated replication-efficient vaccinia virus strain

Replication competent attenuated vaccinia viruses with deletion of...

Cell-based vehicles for potentiation of viral therapy

Immuno-oncolytic therapies

Therapeutic agents and uses thereof for drugs for treatment of tumo...

Anti-cancer oncolytic virus combination therapies and elite respond...

Use of inactivated nonreplicating modified vaccinia virus Ankara (M...

Genetically engineered vaccinia viruses

Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...

Oncolytic viruses targeting STAT3

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Schwann cell differentiation promoting agent and a peripheral nerve...

Clonal strains of attenuated vaccinia viruses and methods of use th...

Test method

High mobility group box I mutant

Non-genetic modification of enveloped viruses

Method of treatment using oncolytic viruses

Genetically engineered vaccinia viruses

Genetically engineered vaccinia viruses

Oncolytic vaccinia virus mutants and using same for cancer treatment

Methods and compositions for production of vaccina virus

Patents Applicationslast 30 patents

Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling

Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling

INTERLEUKIN 7 AND INTERLEUKIN 21 FUSION PROTEINS

Expression of Bacterial Dinucleotide Cyclases

MODIFIED ORTHOPOXVIRUS VECTORS

MODIFIED ORTHOPOXVIRUS VECTORS

ONCOLYTIC VIRUSES TARGETING STAT3

NOVEL RECOMBINANT VACCINIA VIRUS AND USE THEREOF

IMMUNO-MODULATED REPLICATION-EFFICIENT VACCINIA VIRUS STRAIN

Oncolytic Vaccinia Virus

Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling

RECOMBINANT VACCINIA VIRUS

METHODS OF MANUFACTURING ACTIVATED IMMUNE CELLS

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

CELL-BASED VEHICLES FOR POTENTIATION OF VIRAL THERAPY

Immuno-Oncolytic Therapies

CLONAL STRAINS OF ATTENUATED VACCINIA VIRUSES AND METHODS OF USE TH...

DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR M...

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING ANTICANCE...

IRF MODULATOR-EXPRESSING ONCOLYTIC VIRUSES FOR TREATING CANCER

THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...

GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF US...

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING VACCINIA...

Striatin interacting protein inhibitor and use thereof in preparati...

ONCOLYTIC VACCINIA VIRUS

USE OF POXVIRUS WITH AUTOLOGOUS INDUCED PLURIPOTENT STEM CELLS FOR...

ONCOLYTIC VIRUSES TARGETING STAT3

ONCOLYTIC VIRUSES TARGETING STAT3

ENGINEERED ONCOLYTIC VIRUSES EXPRESSING PD-L1 INHIBITORS AND USES T...

M2-DEFECTIVE POXVIRUS